INDI vs RDVT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
INDI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 3/9, indicating poor financial health. The most critical red flag is a negative gross margin of -31.03%, meaning the company loses money on every unit sold before accounting for operating expenses. Despite a 'Strong Buy' analyst consensus and a high target price of $6.04, the company has failed to beat earnings estimates in the last four quarters and shows 0% YoY revenue growth. The disconnect between analyst optimism and the actual financial decay suggests a high-risk speculative profile.
RDVT presents a dichotomy between exceptional balance sheet health and concerning internal sentiment. While the Piotroski F-Score of 4/9 indicates stability and the company maintains a near-zero debt profile with massive liquidity, the stock is trading at a significant premium to its Graham Number ($12.08) and Intrinsic Value ($26.85). Explosive YoY earnings growth is offset by a bearish technical trend and a highly alarming pattern of C-suite insider selling. Consequently, the strong analyst 'buy' ratings are currently contradicted by the actions of the company's own executives.
Compare Another Pair
Related Comparisons
INDI vs RDVT: Head-to-Head Comparison
This page compares indie Semiconductor, Inc. (INDI) and Red Violet, Inc. (RDVT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.